+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Modafinil Tablets Market - Global Forecast 2025-2030- Product Image
Modafinil Tablets Market - Global Forecast 2025-2030- Product Image
Sale

Modafinil Tablets Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6140222
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The evolution of modafinil tablets from a niche therapy for sleep disorders to a widely recognized cognitive enhancement tool represents a pivotal shift in pharmaceutical innovation. Originally developed to treat conditions such as narcolepsy and obstructive sleep apnea, modafinil has garnered interest for its ability to improve alertness and performance under demanding circumstances. This expanded recognition has prompted both clinicians and researchers to explore broader therapeutic applications and new patient populations.

Against a backdrop of regulatory scrutiny, evolving patient expectations, and rapid scientific advances, the modafinil landscape has undergone significant transformation. Clinicians are tailoring treatment protocols with greater precision, while pharmaceutical developers invest in novel formulations and delivery mechanisms. Meanwhile, the convergence of digital health platforms and remote monitoring has enhanced patient engagement, allowing for real-time adjustments to dosing and adherence support.

By situating modafinil within this dynamic context, decision-makers can better appreciate its multifaceted potential. This introductory overview sets the stage for a comprehensive examination of the forces redefining how modafinil is produced, distributed, and utilized in contemporary medical and cognitive enhancement settings.

Recent paradigm shifts in cognitive enhancement therapies have redefined how modafinil tablets are perceived, prescribed, and integrated into diverse treatment protocols

Over the past several years, the landscape of modafinil tablets has been reshaped by a series of transformative shifts. Advances in clinical research have underscored new mechanisms of action, prompting healthcare providers to reconsider traditional protocols and broaden their prescribing practices. Simultaneously, generics have gained traction, challenging branded formulations to innovate in terms of dosage design and patient support services.

The rise of telemedicine has had a profound impact on modafinil accessibility and prescribing behaviors. Virtual consultations enable specialists to reach underserved populations, facilitating earlier intervention and continuous monitoring. At the same time, digital adherence tools and wearable technologies have become integral in ensuring that patients achieve optimal therapeutic outcomes.

As a result, the modafinil market is no longer confined to conventional sleep disorder therapies. Growing interest in cognitive performance enhancement across professional and academic environments has incentivized manufacturers to explore tailored formulations aimed at specific end user segments. These converging trends mark a significant departure from past paradigms, signaling a new era of personalized and technology-enabled therapeutic solutions.

Assessing the ripple effects of new 2025 United States import tariffs on modafinil supply chains, pricing dynamics, and stakeholder strategies across the pharmaceutical sector

The introduction of revised United States import tariffs in 2025 has prompted stakeholders across the pharmaceutical supply chain to reassess sourcing strategies for active pharmaceutical ingredients and finished modafinil products. Manufacturers reliant on overseas production have encountered increased cost pressures, leading to renegotiations with contract manufacturers and a renewed focus on nearshoring opportunities.

Importers and distributors are adapting by optimizing inventory management practices and exploring alternative raw material suppliers. These adjustments are designed to mitigate tariff-related cost escalations and maintain competitive pricing structures. Additionally, enhanced collaboration between legal and regulatory teams has become imperative to ensure compliance with new customs requirements and minimize clearance delays.

In parallel, pharmaceutical companies are investing in localized manufacturing capabilities and strategic partnerships within tariff-exempt jurisdictions. By diversifying their geographic footprint, these organizations aim to insulate their operations from further geopolitical shifts and safeguard supply chain resilience. The cumulative impact of the 2025 tariff changes underscores the need for agile procurement strategies and robust risk management frameworks.

In-depth segmentation analysis uncovers how variations in formulation, dosage, distribution channels, user types, and treatment applications are shaping modafinil utilization

Segmenting the modafinil market reveals nuanced performance dynamics driven by formulation type, dosage levels, distribution channels, consumer demographics, and therapeutic applications. When comparing branded products against generic alternatives, branded formulations often command premium positioning due to proprietary delivery technologies and patient support programs, whereas generics compete on cost efficiency and accessibility.

Dosage differentiation plays a pivotal role in capturing diverse patient needs. The lower 100 mg strength serves as an entry point for new users seeking minimal dosing intervention, while the higher 200 mg tablets address cases requiring more pronounced alertness and sustained cognitive support. These dosage tiers intersect with distribution strategies that span hospital pharmacies offering clinician-supervised dispensation, online pharmacies catering to remote prescription fulfillment, and retail pharmacies providing in-store consultations and immediate availability.

Beyond formulation and distribution nuances, end user categorizations-from clinical settings and home care environments to hospital administrations-drive tailored service models and adherence programs. Furthermore, therapeutic application segments exhibit distinct growth trajectories. In cognitive enhancement, professionals and students adopt modafinil for improved focus and sustained performance during extended work or study sessions. Conversely, sleep disorder treatment encompasses multiple subcategories, including narcolepsy, obstructive sleep apnea, and shift work sleep disorder, each demanding specific dosing regimens and patient monitoring protocols. This multi-layered segmentation framework underscores the complexity of product positioning and the need for specialized strategies across each cluster of demand.

Regional analysis reveals distinct adoption trends, regulatory landscapes, and market drivers for modafinil tablets across the Americas, Europe, Middle East & Africa, and Asia-Pacific regions

Regional patterns in modafinil adoption reflect distinct regulatory frameworks, healthcare infrastructure maturity, and cultural attitudes toward cognitive and sleep disorder therapies. In the Americas, robust clinical trial ecosystems and progressive reimbursement policies have accelerated the integration of modafinil into both therapeutic and performance enhancement contexts. Cross-border pharmaceutical trade networks further enhance product accessibility.

Within Europe, the Middle East, and Africa, regulatory harmonization efforts coexist alongside varied national policies. Western European countries emphasize rigorous post-marketing surveillance and patient support initiatives, while emerging markets in the Middle East and Africa prioritize cost-effective generic alternatives to expand access. These divergent approaches create a mosaic of uptake rates and strategic priorities across the region.

In Asia-Pacific, a combination of large patient populations and increasing healthcare expenditure underpins strong demand growth. Local manufacturers are investing in capacity expansions and regulatory certifications to serve domestic and export markets. Meanwhile, public health campaigns in several Asia-Pacific nations underscore the importance of sleep health, fueling interest in therapeutic interventions for sleep apnea and related disorders. This regional mosaic underscores how localized policies and demand drivers shape the trajectory of modafinil tablet utilization around the globe.

Competitive landscape assessment identifies leading pharmaceutical innovators, strategic collaborations, and emerging players driving advancements in modafinil development and distribution

A review of the competitive landscape highlights a balance between established pharmaceutical innovators and agile generic manufacturers. Leading brand owners maintain their dominance through ongoing research into novel delivery forms and extended-release technologies, as well as comprehensive patient education programs designed to optimize adherence and therapeutic outcomes.

At the same time, generic producers leverage streamlined manufacturing processes and cost-effective supply chains to deliver competitive pricing without compromising on quality standards. Strategic collaborations between originator companies and contract development organizations have also emerged as a prevalent model, facilitating rapid scale-up of production capacities and enabling co-marketing initiatives in key territories.

In addition, several mid-market entrants are differentiating themselves by focusing on niche segments within the cognitive enhancement and sleep disorder treatment domains. These players invest in targeted clinical studies and digital health integrations, such as mobile dosing trackers and telehealth support, to build brand credibility and foster patient loyalty. Collectively, these strategic maneuvers underscore how both heritage and emerging companies are shaping the future of modafinil tablet availability and patient engagement worldwide.

Strategic guidance for pharmaceutical executives to navigate regulatory changes, optimize supply chains, and capitalize on emerging therapeutic opportunities for modafinil tablets

Industry leaders preparing for the next phase of modafinil evolution should prioritize supply chain diversification by establishing partnerships in tariff-friendly jurisdictions and strengthening relationships with multiple ingredient suppliers. This proactive approach will mitigate the risk of sudden cost increases and regulatory bottlenecks.

Simultaneously, investing in dosage and formulation innovation can capture unmet needs across cognitive enhancement and sleep disorder treatment segments. Tailored extended-release platforms, patient adherence support tools, and personalized dosing regimens will enhance product differentiation and foster deeper engagement among both professional and academic user groups.

Moreover, forging strategic alliances with healthcare providers and digital health innovators will facilitate seamless integration of remote monitoring and telemedicine services. By aligning product offerings with compliance-enhancing technologies and real-time therapeutic feedback, companies can position themselves at the forefront of personalized medicine. Finally, decision-makers should leverage robust data analytics to track regional performance nuances and refine market entry strategies accordingly, ensuring that resource allocation aligns with evolving patient demand and regulatory shifts.

Robust research framework combining primary interviews, secondary data triangulation, and rigorous quality assurance protocols underpins the comprehensive analysis of modafinil trends

This research employs a comprehensive framework that synthesizes primary and secondary sources to ensure rigorous analysis. In the primary phase, in-depth interviews were conducted with key opinion leaders, including neurologists, sleep medicine specialists, and procurement managers at hospital networks. These discussions provided qualitative insights into prescribing trends, patient adherence challenges, and the impact of recent policy changes.

Secondary data collection involved an extensive review of scientific literature, patent filings, regulatory filings, and customs documentation related to pharmaceutical tariffs. This information was triangulated with trade databases and industry conference proceedings to validate emerging trends and triangulate cost impact assessments.

Throughout the study, a multi-tier quality assurance process was applied. Data points were cross-checked by research analysts and peer reviewed by domain experts. Additionally, regional country profilers with specialized regulatory expertise ensured that localized nuances were accurately represented. This methodological rigor underpins the credibility of the findings and provides a transparent basis for strategic decision-making.

Summative reflections emphasize the evolving role of modafinil tablets in medical and cognitive enhancement contexts and outline strategic imperatives for future market engagement

In conclusion, the modafinil tablet landscape is marked by dynamic shifts in regulatory environments, therapeutic applications, and distribution models. The convergence of cognitive enhancement demand, evolving sleep disorder treatment protocols, and tariff-driven supply chain adaptations underscores the need for agile strategies and continual innovation.

Segmentation analyses reveal diverse stakeholder priorities, from branded versus generic formulations and dosage customization to distribution strategies that span hospital to online pharmacies and varied end use contexts. Regional distinctions further highlight the importance of tailoring approaches to specific regulatory regimes and cultural attitudes toward treatment.

As the industry moves forward, collaboration between pharmaceutical innovators, healthcare providers, and technology partners will be critical to addressing emerging challenges and unlocking new growth pathways. By leveraging data-driven insights and adopting a patient-centric mindset, organizations can navigate this evolving terrain and deliver value-driven solutions that meet both clinical and performance enhancement objectives.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Branded
    • Generic
  • Dosage Strength
    • 100 Mg
    • 200 Mg
  • Distribution Channel
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • End User
    • Clinics
    • Home Care
    • Hospitals
  • Application
    • Cognitive Enhancement
      • Professional Use
      • Student Use
    • Sleep Disorder Treatment
      • Narcolepsy
      • Obstructive Sleep Apnea
      • Shift Work Sleep Disorder
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Teva Pharmaceutical Industries Ltd
  • Sandoz International GmbH
  • Mylan N.V.
  • Sun Pharmaceutical Industries Ltd
  • Hetero Drugs Pvt Ltd
  • Intas Pharmaceuticals Ltd
  • Dr. Reddy's Laboratories Ltd
  • Cipla Ltd
  • Glenmark Pharmaceuticals Ltd
  • HAB Pharmaceuticals & Research Ltd

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing off-label use of modafinil for cognitive enhancement among professionals
5.2. Regulatory scrutiny over modafinil prescription guidelines and access controls
5.3. Growth of generic modafinil formulations driving price competition in major markets
5.4. Expansion of telemedicine platforms facilitating online modafinil prescriptions
5.5. Rising demand for modafinil in shift work disorder management across industries
5.6. Innovations in sustained release modafinil formulations to improve patient compliance
5.7. Impact of patent expirations on branded modafinil manufacturers’ revenue streams
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Modafinil Tablets Market, by Product Type
8.1. Introduction
8.2. Branded
8.3. Generic
9. Modafinil Tablets Market, by Dosage Strength
9.1. Introduction
9.2. 100 Mg
9.3. 200 Mg
10. Modafinil Tablets Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Pharmacies
10.4. Retail Pharmacies
11. Modafinil Tablets Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Home Care
11.4. Hospitals
12. Modafinil Tablets Market, by Application
12.1. Introduction
12.2. Cognitive Enhancement
12.2.1. Professional Use
12.2.2. Student Use
12.3. Sleep Disorder Treatment
12.3.1. Narcolepsy
12.3.2. Obstructive Sleep Apnea
12.3.3. Shift Work Sleep Disorder
13. Americas Modafinil Tablets Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Modafinil Tablets Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Modafinil Tablets Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Teva Pharmaceutical Industries Ltd
16.3.2. Sandoz International GmbH
16.3.3. Mylan N.V.
16.3.4. Sun Pharmaceutical Industries Ltd
16.3.5. Hetero Drugs Pvt Ltd
16.3.6. Intas Pharmaceuticals Ltd
16.3.7. Dr. Reddy's Laboratories Ltd
16.3.8. Cipla Ltd
16.3.9. Glenmark Pharmaceuticals Ltd
16.3.10. HAB Pharmaceuticals & Research Ltd
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. MODAFINIL TABLETS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL MODAFINIL TABLETS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS MODAFINIL TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS MODAFINIL TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES MODAFINIL TABLETS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES MODAFINIL TABLETS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MODAFINIL TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MODAFINIL TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC MODAFINIL TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC MODAFINIL TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. MODAFINIL TABLETS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. MODAFINIL TABLETS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. MODAFINIL TABLETS MARKET: RESEARCHAI
FIGURE 26. MODAFINIL TABLETS MARKET: RESEARCHSTATISTICS
FIGURE 27. MODAFINIL TABLETS MARKET: RESEARCHCONTACTS
FIGURE 28. MODAFINIL TABLETS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. MODAFINIL TABLETS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MODAFINIL TABLETS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MODAFINIL TABLETS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY 100 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY 100 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY 200 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY 200 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY PROFESSIONAL USE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY PROFESSIONAL USE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY STUDENT USE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY STUDENT USE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY NARCOLEPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY NARCOLEPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY OBSTRUCTIVE SLEEP APNEA, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY OBSTRUCTIVE SLEEP APNEA, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY SHIFT WORK SLEEP DISORDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY SHIFT WORK SLEEP DISORDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS MODAFINIL TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS MODAFINIL TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS MODAFINIL TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS MODAFINIL TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES MODAFINIL TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES MODAFINIL TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES MODAFINIL TABLETS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES MODAFINIL TABLETS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 89. CANADA MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 90. CANADA MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 91. CANADA MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 92. CANADA MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 93. CANADA MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 94. CANADA MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 95. CANADA MODAFINIL TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. CANADA MODAFINIL TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. CANADA MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. CANADA MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. CANADA MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2018-2024 (USD MILLION)
TABLE 100. CANADA MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2025-2030 (USD MILLION)
TABLE 101. CANADA MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2018-2024 (USD MILLION)
TABLE 102. CANADA MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2025-2030 (USD MILLION)
TABLE 103. MEXICO MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 104. MEXICO MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 105. MEXICO MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 106. MEXICO MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 107. MEXICO MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. MEXICO MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. MEXICO MODAFINIL TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. MEXICO MODAFINIL TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. MEXICO MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 112. MEXICO MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 113. MEXICO MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2018-2024 (USD MILLION)
TABLE 114. MEXICO MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2025-2030 (USD MILLION)
TABLE 115. MEXICO MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2018-2024 (USD MILLION)
TABLE 116. MEXICO MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL MODAFINIL TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL MODAFINIL TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA MODAFINIL TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA MODAFINIL TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA MODAFINIL TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA MODAFINIL TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA MODAFINIL TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA MODAFINIL TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 162. UNITED KINGDOM MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 164. UNITED KINGDOM MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. UNITED KINGDOM MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM MODAFINIL TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM MODAFINIL TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2025-2030 (USD MILLION)
TABLE 175. GERMANY MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 176. GERMANY MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 177. GERMANY MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 178. GERMANY MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 179. GERMANY MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. GERMANY MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. GERMANY MODAFINIL TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. GERMANY MODAFINIL TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. GERMANY MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. GERMANY MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. GERMANY MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2018-2024 (USD MILLION)
TABLE 186. GERMANY MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2025-2030 (USD MILLION)
TABLE 187. GERMANY MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2018-2024 (USD MILLION)
TABLE 188. GERMANY MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2025-2030 (USD MILLION)
TABLE 189. FRANCE MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 190. FRANCE MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 191. FRANCE MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 192. FRANCE MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 193. FRANCE MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 194. FRANCE MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 195. FRANCE MODAFINIL TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. FRANCE MODAFINIL TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. FRANCE MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 198. FRANCE MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 199. FRANCE MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2018-2024 (USD MILLION)
TABLE 200. FRANCE MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2025-2030 (USD MILLION)
TABLE 201. FRANCE MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2018-2024 (USD MILLION)
TABLE 202. FRANCE MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2025-2030 (USD MILLION)
TABLE 203. RUSSIA MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 204. RUSSIA MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 205. RUSSIA MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 206. RUSSIA MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 207. RUSSIA MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. RUSSIA MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA MODAFINIL TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA MODAFINIL TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2025-2030 (USD MILLION)
TABLE 217. ITALY MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 218. ITALY MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 219. ITALY MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 220. ITALY MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 221. ITALY MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. ITALY MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. ITALY MODAFINIL TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. ITALY MODAFINIL TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. ITALY MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 226. ITALY MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 227. ITALY MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2018-2024 (USD MILLION)
TABLE 228. ITALY MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2025-2030 (USD MILLION)
TABLE 229. ITALY MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2018-2024 (USD MILLION)
TABLE 230. ITALY MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2025-2030 (USD MILLION)
TABLE 231. SPAIN MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 232. SPAIN MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 233. SPAIN MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 234. SPAIN MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 235. SPAIN MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. SPAIN MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. SPAIN MODAFINIL TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. SPAIN MODAFINIL TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. SPAIN MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 240. SPAIN MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 241. SPAIN MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2018-2024 (USD MILLION)
TABLE 242. SPAIN MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2025-2030 (USD MILLION)
TABLE 243. SPAIN MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2018-2024 (USD MILLION)
TABLE 244. SPAIN MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2025-2030 (USD MILLION)
TABLE 245. UNITED ARAB EMIRATES MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 246. UNITED ARAB EMIRATES MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES MODAFINIL TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES MODAFINIL TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2025-2030 (USD MILLION)
TABLE 259. SAUDI ARABIA MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 260. SAUDI ARABIA MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 261. SAUDI ARABIA MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 262. SAUDI ARABIA MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. SAUDI ARABIA MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA MODAFINIL TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA MODAFINIL TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2025-2030 (USD MILLION)
TABLE 273. SOUTH AFRICA MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 274. SOUTH AFRICA MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 276. SOUTH AFRICA MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 278. SOUTH AFRICA MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA MODAFINIL TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. SOUTH AFRICA MODAFINIL TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 282. SOUTH AFRICA MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2018-2024 (USD MILLION)
TABLE 284. SOUTH AFRICA MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2025-2030 (USD MILLION)
TABLE 287. DENMARK MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 288. DENMARK MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 289. DENMARK MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 290. DENMARK MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 291. DENMARK MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 292. DENMARK MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 293. DENMARK MODAFINIL TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. DENMARK MODAFINIL TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. DENMARK MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 296. DENMARK MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 297. DENMARK MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2018-2024 (USD MILLION)
TABLE 298. DENMARK MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2025-2030 (USD MILLION)
TABLE 299. DENMARK MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2018-2024 (USD MILLION)
TABLE 300. DENMARK MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2025-2030 (USD MILLION)
TABLE 301. NETHERLANDS MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 302. NETHERLANDS MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 303. NETHERLANDS MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 304. NETHERLANDS MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 305. NETHERLANDS MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 306. NETHERLANDS MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 307. NETHERLANDS MODAFINIL TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. NETHERLANDS MODAFINIL TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. NETHERLANDS MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 310. NETHERLANDS MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 311. NETHERLANDS MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2018-2024 (USD MILLION)
TABLE 312. NETHERLANDS MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2025-2030 (USD MILLION)
TABLE 313. NETHERLANDS MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2018-2024 (USD MILLION)
TABLE 314. NETHERLANDS MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2025-2030 (USD MILLION)
TABLE 315. QATAR MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 316. QATAR MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 317. QATAR MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 318. QATAR MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 319. QATAR MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 320. QATAR MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 321. QATAR MODAFINIL TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 322. QATAR MODAFINIL TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 323. QATAR MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 324. QATAR MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 325. QATAR MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2018-2024 (USD MILLION)
TABLE 326. QATAR MODAFINIL TABLETS MARKET SIZE, BY COGNITIVE ENHANCEMENT, 2025-2030 (USD MILLION)
TABLE 327. QATAR MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2018-2024 (USD MILLION)
TABLE 328. QATAR MODAFINIL TABLETS MARKET SIZE, BY SLEEP DISORDER TREATMENT, 2025-2030 (USD MILLION)
TABLE 329. FINLAND MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 330. FINLAND MODAFINIL TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 331. FINLAND MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 332. FINLAND MODAFINIL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 333. FINLAND MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 334. FINLAND MODAFINIL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 335. FINLAND MODAFINIL TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 336. FINLAND MODAFINIL TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 337. FINLAND MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 338. FINLAND MODAFINIL TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Modafinil Tablets market report include:
  • Teva Pharmaceutical Industries Ltd
  • Sandoz International GmbH
  • Mylan N.V.
  • Sun Pharmaceutical Industries Ltd
  • Hetero Drugs Pvt Ltd
  • Intas Pharmaceuticals Ltd
  • Dr. Reddy's Laboratories Ltd
  • Cipla Ltd
  • Glenmark Pharmaceuticals Ltd
  • HAB Pharmaceuticals & Research Ltd

Related Topics

Related Reports

Narcolepsy Drugs Market - Global Forecast 2025-2030 - Product Image

Narcolepsy Drugs Market - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Modafinil Oral Drugs Market - Global Forecast 2025-2030 - Product Image

Modafinil Oral Drugs Market - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Modafinil (CAS 68693-11-8) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Modafinil (CAS 68693-11-8) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Nimesulide Dispersible Tablet Global Market Report 2025 - Product Image

Nimesulide Dispersible Tablet Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Imipramine Hydrochloride Tablet Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application - Product Image

Imipramine Hydrochloride Tablet Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application

  • Report
  • 74 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.